Lactose (India) Ltd | 122 Cr. | 96.6 | 247/84.3 | 27.7 | 46.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 4.49 Cr. | 2.35 | 4.33/2.28 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 30.8 Cr. | 41.5 | 94.9/41.0 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 32.2 Cr. | 22.0 | 29.1/13.4 | 33.5 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 64.2 Cr. | 85.3 | 155/79.0 | 16.9 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 57,699 Cr. | 2,045 | 2,286/1,275 | 43.3 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 276 Cr. | 12.1 | 29.0/11.2 | 16.7 | 8.21 | 0.00 % | 12.5 % | 9.09 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 21.7/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 494 Cr. | 1,047 | 1,143/635 | 21.1 | 299 | 0.07 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 117 Cr. | 23.4 | 32.0/15.0 | 35.8 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,057 Cr. | 359 | 449/219 | 10.3 | 123 | 0.70 % | 23.0 % | 24.7 % | 5.00 |
Fabino Enterprises Ltd | 5.46 Cr. | 26.0 | 39.0/22.8 | 42.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 9.56 Cr. | 3.84 | 9.54/2.11 | 106 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 339 Cr. | 349 | 477/112 | 54.6 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,249 Cr. | 1,206 | 1,584/1,078 | 51.2 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 127 Cr. | 0.62 | 1.24/0.48 | 16.9 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 46.0 Cr. | 19.1 | 26.3/6.40 | 47.4 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.9 Cr. | 10.8 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 175 Cr. | 491 | 999/486 | 9.49 | 563 | 0.41 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 52.0 Cr. | 52.0 | 67.0/26.1 | 133 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.8 Cr. | 43.3 | 88.7/37.9 | 41.2 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 8.00 Cr. | 3.20 | 17.2/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.6 Cr. | 131 | 154/59.6 | | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 22.0 Cr. | 40.3 | 45.4/6.08 | 245 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 41.5 Cr. | 55.0 | 85.5/0.00 | 48.3 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.40 Cr. | 18.0 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,683 Cr. | 789 | 1,028/455 | 38.2 | 65.3 | 0.13 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 95.4 Cr. | 22.1 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 10.3 Cr. | 20.3 | 46.0/17.4 | 44.7 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 159 Cr. | 276 | 418/241 | 16.7 | 119 | 1.63 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 53.8 Cr. | 37.5 | 62.6/14.8 | 48.5 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 63,492 Cr. | 1,084 | 1,593/994 | 18.7 | 557 | 0.42 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 164 Cr. | 264 | 303/170 | 238 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 886 Cr. | 88.4 | 123/74.0 | 19.2 | 32.5 | 1.70 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 37.2 Cr. | 28.5 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 10,643 Cr. | 1,300 | 1,379/600 | 56.4 | 160 | 0.12 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.69 Cr. | 0.71 | 1.45/0.66 | 93.8 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 259 Cr. | 33.8 | 69.8/30.0 | 13.8 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 8.67 Cr. | 14.8 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 119 Cr. | 5.05 | 6.25/2.82 | 216 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 70,688 Cr. | 33,265 | 37,000/25,260 | 48.7 | 1,992 | 1.43 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 6,866 Cr. | 758 | 972/521 | 25.8 | 220 | 0.33 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 187 Cr. | 65.8 | 75.8/31.3 | 44.8 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,150 Cr. | 1,378 | 1,387/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 24,779 Cr. | 1,525 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 828 Cr. | 252 | 330/154 | 19.3 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 633 Cr. | 474 | 568/270 | 13.6 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,543 Cr. | 503 | 950/483 | 28.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,598 Cr. | 1,131 | 1,923/991 | 23.7 | 754 | 0.88 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,22,613 Cr. | 3,623 | 3,790/2,886 | 60.7 | 224 | 0.88 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 933 Cr. | 101 | 317/99.2 | | 43.7 | 0.49 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,633 Cr. | 17.4 | 27.9/14.1 | 28.7 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,129 Cr. | 235 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,93,827 Cr. | 1,641 | 1,960/1,553 | 34.4 | 301 | 0.97 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,655 Cr. | 597 | 886/441 | 108 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,081 Cr. | 235 | 398/175 | 29.6 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 326 Cr. | 1,080 | 1,750/956 | 21.4 | 650 | 0.14 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,886 Cr. | 909 | 1,003/530 | 69.1 | 243 | 0.11 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,400 Cr. | 176 | 241/111 | 146 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 11,690 Cr. | 5,076 | 7,600/4,146 | 32.8 | 340 | 2.30 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,742 Cr. | 2,263 | 2,977/1,772 | 36.1 | 321 | 0.88 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,449 Cr. | 6,295 | 6,500/4,863 | 34.8 | 323 | 1.99 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 221 Cr. | 62.8 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 24,374 Cr. | 5,328 | 6,453/3,701 | 36.1 | 922 | 0.66 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 122 Cr. | 99.1 | 348/81.0 | 8.61 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,574 Cr. | 420 | 582/161 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,795 Cr. | 748 | 1,998/604 | 44.5 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 17,036 Cr. | 13,278 | 18,100/10,060 | 129 | 1,188 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 326 Cr. | 14.5 | 56.5/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,662 Cr. | 874 | 1,639/660 | 9.24 | 425 | 0.69 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,542 Cr. | 46.4 | 101/41.7 | 27.4 | 21.1 | 0.43 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 8,093 Cr. | 179 | 359/168 | 23.1 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 131 Cr. | 82.8 | 145/65.5 | | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 355 Cr. | 99.5 | 177/90.2 | 47.4 | 29.0 | 0.00 % | 9.91 % | 9.21 % | 10.0 |
Lupin Ltd | 89,596 Cr. | 1,962 | 2,403/1,774 | 24.2 | 377 | 0.61 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,087 Cr. | 543 | 980/499 | 12.6 | 335 | 0.33 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 46,409 Cr. | 860 | 923/423 | 91.1 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,109 Cr. | 1,069 | 1,235/574 | 25.5 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 162 Cr. | 75.3 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 758 Cr. | 157 | 370/155 | 21.7 | 107 | 1.91 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 744 Cr. | 425 | 500/265 | 27.8 | 116 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 16,822 Cr. | 1,056 | 1,310/802 | 34.8 | 393 | 0.47 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,835 Cr. | 1,717 | 2,030/1,303 | 39.2 | 221 | 0.90 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,632 Cr. | 245 | 328/140 | 38.3 | 36.1 | 1.02 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 34,653 Cr. | 1,366 | 1,758/1,168 | 38.9 | 274 | 0.29 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,711 Cr. | 92.4 | 108/57.5 | 25.8 | 57.5 | 0.87 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 745 Cr. | 101 | 160/67.2 | 33.8 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,630 Cr. | 285 | 388/190 | | 111 | 0.53 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 3,074 Cr. | 249 | 465/248 | 48.6 | 102 | 0.56 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,611 Cr. | 1,894 | 2,786/1,243 | 43.1 | 369 | 0.37 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,575 Cr. | 356 | 504/285 | 58.5 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 11,147 Cr. | 459 | 725/412 | 23.4 | 153 | 0.33 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 57,699 Cr. | 2,045 | 2,286/1,275 | 43.3 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,919 Cr. | 2,770 | 3,516/1,921 | 49.6 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 32,553 Cr. | 1,976 | 2,131/1,200 | 28.6 | 592 | 0.91 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,764 Cr. | 477 | 659/359 | 28.8 | 140 | 1.05 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 22,944 Cr. | 1,684 | 1,910/1,097 | 59.3 | 210 | 0.44 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,05,191 Cr. | 1,260 | 1,421/1,020 | 18.6 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,196 Cr. | 268 | 308/161 | 35.3 | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,26,333 Cr. | 1,564 | 1,702/1,310 | 23.5 | 386 | 0.83 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 16,230 Cr. | 2,135 | 2,641/1,551 | 28.8 | 375 | 0.28 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 444 Cr. | 151 | 203/94.2 | 219 | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,786 Cr. | 169 | 191/105 | 16.8 | 99.7 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 71.1 Cr. | 43.7 | 92.0/40.4 | 25.5 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 48,030 Cr. | 359 | 406/291 | 119 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,933 Cr. | 1,915 | 2,215/1,286 | 42.2 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 140 Cr. | 87.8 | 158/76.3 | 19.6 | 48.6 | 1.37 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 259 Cr. | 109 | 111/67.8 | 25.7 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 20,786 Cr. | 8,314 | 10,691/6,220 | 98.3 | 308 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 1,992 Cr. | 689 | 863/544 | 36.5 | 113 | 0.67 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 199 Cr. | 94.7 | 145/90.4 | 7.56 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 63,937 Cr. | 5,348 | 6,440/4,492 | 28.1 | 1,002 | 0.84 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,810 Cr. | 957 | 1,304/725 | 31.8 | 264 | 1.15 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 462 Cr. | 810 | 1,754/763 | 73.5 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 33,556 Cr. | 2,686 | 3,486/2,022 | 36.1 | 303 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,436 Cr. | 307 | 571/258 | 25.1 | 127 | 1.69 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,474 Cr. | 487 | 635/312 | 25.0 | 136 | 0.21 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,827.46 Cr | 1,180.13 | | 48.68 | 193.78 | 0.34% | 16.52% | 15.17% | 6.18 |